I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Charles Berg Biography and Net Worth

Director of DaVita

Charles G. Berg has been one of our directors since March 2007. From November 2016 until December 2017, Mr. Berg served as executive chair of, DaVita Medical Group (“DMG”), our former integrated healthcare business. From 2008 to 2013, Mr. Berg served as executive chairman of WellCare Health Plans, Inc. (“WellCare”), a provider of managed care services for government-sponsored health care programs. Mr. Berg served as non-executive chairman of the board of directors of WellCare from January 2011 until his retirement in May 2013. From January 2007 to April 2009, Mr. Berg was a senior advisor to Welsh, Carson, Anderson & Stowe, a private equity firm. From April 1998 to July 2004, Mr. Berg held various executive positions, including executive vice president-medical delivery, president and chief operating officer with Oxford Health Plans, Inc. (“Oxford”), a health benefit plan provider. He was the chief executive officer when Oxford was acquired by UnitedHealth Group. He then became an executive of UnitedHealth Group and was primarily responsible for integrating the Oxford business. Mr. Berg also currently serves as a member of the Operating Council & Senior Advisory Board of Consonance Capital Partners, a private equity firm.

What is Charles Berg's net worth?: The estimated net worth of Charles Berg is at least $2.56 million as of March 9th, 2023. Mr. Berg owns 15,733 shares of DaVita stock worth more than $2,557,714 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Berg may own. Learn More about Charles Berg's net worth.
How do I contact Charles Berg?: The corporate mailing address for Mr. Berg and other DaVita executives is 2000 16TH STREET, DENVER CO, 80202. DaVita can also be reached via phone at (720) 631-2100 and via email at [email protected]. Learn More on Charles Berg's contact information.
Has Charles Berg been buying or selling shares of DaVita?: Charles Berg has not been actively trading shares of DaVita within the last three months. Most recently, Charles Berg sold 1,431 shares of the business's stock in a transaction on Thursday, March 9th. The shares were sold at an average price of $75.13, for a transaction totalling $107,511.03. Following the completion of the sale, the director now directly owns 15,733 shares of the company's stock, valued at $1,182,020.29. Learn More on Charles Berg's trading history.
Who are DaVita's active insiders?: DaVita's insider roster includes Joel Ackerman (CFO), Pamela Arway (Director), Charles Berg (Director), Barbara Desoer (Director), Paul Diaz (Director), James Hearty (Chief Compliance Officer), John Nehra (Director), Paula Price (Director), Javier Rodriguez (CEO), Michael Staffieri (COO), Kathleen Waters (Insider), and Phyllis Yale (Director). Learn More on DaVita's active insiders.
Are insiders buying or selling shares of DaVita?: In the last year, insiders at the sold shares 11 times. They sold a total of 313,052 shares worth more than $44,636,354.33. The most recent insider tranaction occured on September, 16th when CEO Javier Rodriguez sold 50,000 shares worth more than $8,252,500.00. Insiders at DaVita own 2.0% of the company. Learn More about insider trades at DaVita.
Information on this page was last updated on 9/16/2024.

Charles Berg Insider Trading History at DaVita

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/9/2023	Sell	1,431	$75.13	$107,511.03	15,733
3/1/2023	Sell	735	$81.78	$60,108.30	17,164
5/4/2021	Sell	1,872	$122.52	$229,357.44	17,463
6/8/2020	Sell	357	$87.53	$31,248.21	15,666
5/14/2018	Sell	338	$66.25	$22,392.50	29,776
12/11/2017	Sell	7,048	$69.24	$488,003.52	5,359
5/9/2017	Sell	8,414	$65.80	$553,641.20	34,719

Charles Berg Buying and Selling Activity at DaVita

DaVita Company Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Today's Range

Now: $162.57

$161.38

$163.82

50 Day Range

MA: $158.14

$139.81

$165.19

2 Week Range

Now: $162.57

$97.31

$168.50

Volume

79,827 shs

Average Volume

819,343 shs

Market Capitalization

$13.33 billion

P/E Ratio

17.54

Dividend Yield

N/A

Beta

0.89

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad

In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate